Search & Analyze
Popular Searches
Venus Remedies Ltd.
Healthcare₹1,642.001.85%
24 Jul, 4:01 PM
CMP₹1,642.00
Mkt Cap₹2.24K Cr
P/E19.29
P/B3.26
ROE8.64%
52W High₹2,043.15
52W Low₹423.70
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
19.29
P/B Ratio
3.26
EV/EBITDA
12.43
Price/Sales
2.76
Dividend Yield (%)
0.60
EPS (TTM ₹)
86.91
Book Value (₹)
513.74
ROE (%)
8.64
ROCE (%)
13.17
ROA (%)
6.75
EBITDA Margin (%)
9.81
Net Profit Margin (%)
6.99
Debt/Equity
0.00
Current Ratio
3.31
Interest Coverage
1099.26
Asset Turnover
0.97
Working Capital/Sales
2.05
Core EBITDA Growth (%)
18.69
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 54812.35 | 60018.09 | 55550.95 | 60144.96 | 64788.6 |
| Net Sales | 54812.35 | 60018.09 | 55550.95 | 60144.96 | 64788.6 |
| Total Income | 56775.33 | 60848.97 | 56583.13 | 61302.93 | 66884.17 |
| Total Expenditure | 49434.64 | 53806.68 | 49548.51 | 54184.92 | 58435.7 |
| Operating Profit | 7340.69 | 7042.29 | 7034.62 | 7118.01 | 8448.47 |
| Depreciation | 3527.61 | 3353.38 | 3229.78 | 2644.31 | 2250.61 |
| Exceptional Items | 2344.19 | — | — | — | 991.32 |
| Profit Before Tax | 4855.34 | 3640.81 | 3793.04 | 4464.33 | 7182.64 |
| Tax | -1321.2 | -431.61 | 1136.46 | 1615.25 | 2651.17 |
| Profit After Tax (PAT) | 6176.54 | 4072.42 | 2656.58 | 2849.08 | 4531.47 |
| EPS (₹) | 50.04 | 30.86 | 19.88 | 21.31 | 33.9 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1234.2 | 1336.7 | 1336.7 | 1336.7 | 1336.7 |
| Reserves | 37418.96 | 42707.97 | 44696.91 | 47418.31 | 54758.25 |
| Shareholders Funds | 40028.37 | 44044.67 | 46033.61 | 48755.01 | 56094.95 |
| Total Debt | 5131.84 | 4284.5 | 4229.31 | 4132.52 | 169.25 |
| Total Liabilities | 55585.33 | 57913.59 | 60108 | 62682.18 | 71572.15 |
| Total Assets | 55585.33 | 57913.59 | 60108 | 62682.18 | 71572.15 |
| Book Value / Share | 313.1839 | 329.503 | 344.3825 | 364.7416 | 419.6525 |
| Assets | 55585.33 | 57913.59 | 60108 | 62682.18 | 71572.15 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 13183.68 | 4110.18 | 3662.74 | 3728.54 | 8644.21 |
| Investing Activities | 5649.38 | -1672.69 | -5082.96 | -720.93 | -7624.77 |
| Financing Activities | -16224.26 | -947.71 | -56.75 | -108.27 | -101.92 |
| Net Cash Flow | 2608.8 | 1489.78 | -1476.97 | 2899.34 | 917.52 |
VENUSREM
₹1,642.00
+1.85%